Cite
NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL
MLA
Sara Gabrielli, et al. NOTCH1 Mutations in +12 Chronic Lymphocytic Leukemia (CLL) Confer an Unfavorable Prognosis, Induce a Distinctive Transcriptional Profiling and Refine the Intermediate Prognosis of +12 CLL. Mar. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2870a1fc42b5415dd39579d2fd281c26&authtype=sso&custid=ns315887.
APA
Sara Gabrielli, Sabina Chiaretti, Davide Rossi, Ilaria Del Giudice, Silvia Rasi, Robin Foà, Roberto Marasca, Marilisa Marinelli, Gianluca Gaidano, Marco Fangazio, Anna Guarini, Luca Laurenti, & Simona Tavolaro. (2012). NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL.
Chicago
Sara Gabrielli, Sabina Chiaretti, Davide Rossi, Ilaria Del Giudice, Silvia Rasi, Robin Foà, Roberto Marasca, et al. 2012. “NOTCH1 Mutations in +12 Chronic Lymphocytic Leukemia (CLL) Confer an Unfavorable Prognosis, Induce a Distinctive Transcriptional Profiling and Refine the Intermediate Prognosis of +12 CLL,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2870a1fc42b5415dd39579d2fd281c26&authtype=sso&custid=ns315887.